Blood Sugar Monitoring in Type 1 Diabetes: What the Evidence Actually Shows

If you manage Type 1 diabetes, you check your blood sugar regularly—but how often should you really be testing? The honest answer: we don't have strong evidence to guide that decision.

A comprehensive review published in the Cochrane Database of Systematic Reviews examined decades of research on self-monitoring of blood glucose in adults with Type 1 diabetes. The researchers looked for studies comparing different monitoring schedules, different times of day to test, and different blood sugar targets. What they found was surprising: the available evidence is limited and inconsistent, with few studies clearly linking monitoring strategies to meaningful health outcomes.

The review identified critical gaps in our knowledge. Researchers still lack clear answers about:

• How frequently adults should monitor blood glucose each day

• When during the day monitoring is most important (before meals, after meals, at bedtime, or other times)

• What specific blood sugar targets individuals should aim for

These may seem like basic questions, but they form the foundation of daily diabetes management. The lack of consistent evidence means that current guidance varies widely, and people may not receive recommendations tailored to what research actually shows works best.

Self-monitoring of blood glucose is a cornerstone of Type 1 diabetes management. It helps people make real-time decisions about food, activity, and insulin. Yet without clear evidence about optimal monitoring strategies, both patients and healthcare providers are making decisions based on limited information.

The challenge is particularly acute in low-resource settings, where the review found evidence to be especially scarce. People managing diabetes with fewer resources and less access to supplies face unique challenges that research has not adequately addressed.

The Cochrane researchers called for better-designed, longer-term studies that actually measure whether different monitoring approaches lead to better glycaemic control, fewer hypoglycemic events, reduced complications, or improved quality of life. Studies need to run at least 24 weeks and compare real strategies that people actually use.

Until that evidence emerges, conversations between you and your healthcare team remain the best way to develop a monitoring plan that fits your life and goals. What matters most is finding an approach you can sustain consistently.

Source: The Cochrane database of systematic reviews. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.